Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Portfolio Pulse from
Vaccine-maker stocks, including Moderna and Pfizer, fell after President-elect Donald Trump announced Robert F. Kennedy Jr., a known vaccine skeptic, as his pick to lead the U.S. Department of Health and Human Services.
November 14, 2024 | 10:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock fell following the announcement of RFK Jr., a vaccine skeptic, as the head of HHS, raising concerns about future vaccine policies.
Moderna, as a vaccine maker, is directly impacted by the appointment of a vaccine skeptic to a key health position, which could influence vaccine policy and public perception.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Pfizer's stock declined due to the appointment of RFK Jr., a known vaccine skeptic, to lead HHS, potentially affecting vaccine-related policies.
Pfizer, being a major vaccine producer, is affected by the appointment of a vaccine skeptic to a significant health role, which could impact future vaccine policies and market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80